Efficacy and Safety of Empagliflozin or Semaglutide in Overweight/Obese Patients With Type 1 Diabetes

NCT06762314 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

105

Enrollment

OTHER

Sponsor class

Conditions

Diabetes

Interventions

DRUG: Insulin
DRUG: Semaglutide
DRUG: Empagliflozin

Sponsor

Mostafa Bahaa

Collaborators

[object Object]
[object Object]